Back to SANDS CAPITAL MANAGEMENT, LLCRARE
RAREShowing 8 of 12 quarters
Position history for SANDS CAPITAL MANAGEMENT, LLC's holdings in ULTRAGENYX PHARMACEUTICAL IN
SANDS CAPITAL MANAGEMENT, LLC holds 3.2M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $67.3M as of 2026-Q1. The position was decreased (-7.8% shares). RARE represents 0.3% of SANDS CAPITAL MANAGEMENT, LLC's portfolio.
Current Value
$67.3M
Current Shares
3.2M
Total Value Change
-$152.7M
Total Shares Change
-2.1M
Quarter-by-Quarter History
Other major holders of RARE: Capital Research Global Investors, Capital International Investors, FEDERATED HERMES, INC.